TransMedics Group, Inc. (TMDX) stock
TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3030% below fair value
$93.91+1.70 (+1.84%)
Close on Nov 17, 2026Market cap $3.26BP/E 24.4Yield 0.00%
TransMedics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
TransMedics's total debt was $20.00M at Jun 30, 2026. For fiscal 2025 it was $10.00M, down 83.0% from the year before. The highest annual figure on record is $58.70M in fiscal 2022.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.00M | -83.0% |
| FY2022 | Dec 31, 2022 | $58.70M | +66.8% |
| FY2021 | Dec 31, 2021 | $35.20M | +1.6% |
| FY2020 | Dec 31, 2020 | $34.66M | +1.5% |
| FY2019 | Dec 28, 2019 | $34.15M | +1.4% |
| FY2018 | Dec 29, 2018 | $33.67M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $20.00M | -66.0% |
| Q1 FY2026 | Mar 31, 2026 | $15.00M | -74.4% |
| Q4 FY2025 | Dec 31, 2025 | $10.00M | -82.9% |
| Q3 FY2025 | Sep 30, 2025 | $5.00M | -85.9% |
| Q1 FY2023 | Mar 31, 2023 | $58.80M | +66.4% |
| Q4 FY2022 | Dec 31, 2022 | $58.70M | +66.8% |
| Q3 FY2022 | Sep 30, 2022 | $58.54M | +67.0% |
| Q2 FY2022 | Jun 30, 2022 | $35.48M | +1.6% |
| Q1 FY2022 | Mar 31, 2022 | $35.33M | +1.6% |
| Q4 FY2021 | Dec 31, 2021 | $35.20M | +1.6% |
| Q3 FY2021 | Sep 30, 2021 | $35.06M | +1.5% |
| Q2 FY2021 | Jun 30, 2021 | $34.92M | +1.5% |
| Q1 FY2021 | Mar 31, 2021 | $34.79M | +1.5% |
| Q4 FY2020 | Dec 31, 2020 | $34.66M | +1.5% |
| Q3 FY2020 | Sep 30, 2020 | $34.53M | +1.5% |
| Q2 FY2020 | Jun 30, 2020 | $34.40M | +1.5% |
| Q1 FY2020 | Mar 31, 2020 | $34.27M | +1.4% |
| Q4 FY2019 | Dec 28, 2019 | $34.15M | +1.4% |
| Q3 FY2019 | Sep 28, 2019 | $34.02M | – |
| Q2 FY2019 | Jun 29, 2019 | $33.90M | – |
| Q1 FY2019 | Mar 30, 2019 | $33.79M | – |
| Q4 FY2018 | Dec 29, 2018 | $33.67M | – |
See a number that looks wrong?